• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于新型可挤出聚合物通过熔融沉积成型(FDM)3D打印片剂实现的可调药物释放

Tunable Drug Release from Fused Deposition Modelling (FDM) 3D-Printed Tablets Fabricated Using a Novel Extrudable Polymer.

作者信息

Raje Vishvesh, Palekar Siddhant, Banella Sabrina, Patel Ketan

机构信息

College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.

出版信息

Pharmaceutics. 2022 Oct 14;14(10):2192. doi: 10.3390/pharmaceutics14102192.

DOI:10.3390/pharmaceutics14102192
PMID:36297626
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9611745/
Abstract

Three-dimensional (3D) printing is proving to be a pivotal technology for developing personalized dosage forms with bench to bedside feasibility. Fused deposition modelling (FDM) 3D printing has emerged as the most used technique wherein molten drug-loaded polymer filaments are deposited layer-by-layer to fabricate a predefined shape and internal geometry. However, for precise FDM 3D printing, it is imperative for the filaments to have peculiar mechanical/physicochemical properties, which the majority of the FDA/GRAS approved polymers lack. In the current study, a novel water-soluble polymer, Poly(2-ethyl-tetra-oxazoline) [PETOx] has been investigated as an extrudable and printable polymer with two different types of drug molecule—dextromethorphan hydrobromide (DXM) and hydrochlorothiazide (HCTZ). Hot-stage microscopy experiments of drug:polymer (1:1 w/w) and filaments were carried out at 25−275 °C. HCTZ-loaded filament showed higher toughness of 17 ± 3.25 × 106 J/m3 compared with DXM and drug-free filament. Moisture sorption and flexural analysis was performed to understand the correlation of mechanical properties and storage humidity to printability. Varying the number of outer perimeters of each layer (shell number) was observed to affect the drug release pattern from the printlets. The DXM one-shell printlet showed >80%, whereas the DXM five-shell printlet showed >60% of the drug release within 60 min. PETOx could prove to be a high-performance and versatile 3D printable polymer.

摘要

三维(3D)打印正被证明是一种用于开发具有从实验室到床边可行性的个性化剂型的关键技术。熔融沉积建模(FDM)3D打印已成为最常用的技术,其中将载有药物的熔融聚合物长丝逐层沉积以制造预定义的形状和内部几何结构。然而,对于精确的FDM 3D打印,长丝必须具有特殊的机械/物理化学性质,而大多数FDA/GRAS批准的聚合物缺乏这些性质。在当前的研究中,一种新型水溶性聚合物聚(2-乙基-四恶唑啉)[PETOx]已被研究作为一种可挤出和可打印聚合物,用于两种不同类型的药物分子——氢溴酸右美沙芬(DXM)和氢氯噻嗪(HCTZ)。在25−275°C下对药物:聚合物(1:1 w/w)和长丝进行了热台显微镜实验。与DXM和无药物长丝相比,载有HCTZ的长丝显示出更高的韧性,为17±3.25×106 J/m3。进行了水分吸附和弯曲分析,以了解机械性能和储存湿度与可打印性之间的相关性。观察到改变每层的外周数量(壳层数)会影响小打印件的药物释放模式。DXM单壳小打印件在60分钟内显示>80%的药物释放,而DXM五壳小打印件在60分钟内显示>60%的药物释放。PETOx可能被证明是一种高性能且通用的3D可打印聚合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/65a3b4f2782c/pharmaceutics-14-02192-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/e44d26417002/pharmaceutics-14-02192-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/79dda1187f08/pharmaceutics-14-02192-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/2a6865315a4f/pharmaceutics-14-02192-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/b7b8a6e3c71e/pharmaceutics-14-02192-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/7c8a38f03c70/pharmaceutics-14-02192-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/6e8029d2d42e/pharmaceutics-14-02192-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/9fb780b8d4e7/pharmaceutics-14-02192-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/65a3b4f2782c/pharmaceutics-14-02192-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/e44d26417002/pharmaceutics-14-02192-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/79dda1187f08/pharmaceutics-14-02192-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/2a6865315a4f/pharmaceutics-14-02192-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/b7b8a6e3c71e/pharmaceutics-14-02192-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/7c8a38f03c70/pharmaceutics-14-02192-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/6e8029d2d42e/pharmaceutics-14-02192-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/9fb780b8d4e7/pharmaceutics-14-02192-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b6/9611745/65a3b4f2782c/pharmaceutics-14-02192-g008.jpg

相似文献

1
Tunable Drug Release from Fused Deposition Modelling (FDM) 3D-Printed Tablets Fabricated Using a Novel Extrudable Polymer.基于新型可挤出聚合物通过熔融沉积成型(FDM)3D打印片剂实现的可调药物释放
Pharmaceutics. 2022 Oct 14;14(10):2192. doi: 10.3390/pharmaceutics14102192.
2
3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.3D 打印制药口服固体制剂的熔融沉积法:使用增塑 HPMCAS 提高可印刷性。
Int J Pharm. 2022 Mar 25;616:121553. doi: 10.1016/j.ijpharm.2022.121553. Epub 2022 Feb 5.
3
Personalised 3D Printed Medicines: Optimising Material Properties for Successful Passive Diffusion Loading of Filaments for Fused Deposition Modelling of Solid Dosage Forms.个性化3D打印药物:优化材料特性以实现用于固体剂型熔融沉积建模的长丝的成功被动扩散加载。
Pharmaceutics. 2020 Apr 11;12(4):345. doi: 10.3390/pharmaceutics12040345.
4
Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.释放调节剂在熔融沉积成型(FDM)3D 打印片剂中调节药物释放的作用。
Int J Pharm. 2021 Mar 15;597:120315. doi: 10.1016/j.ijpharm.2021.120315. Epub 2021 Feb 1.
5
Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets.用于片剂 3D 打印的聚己内酯热熔挤出纤维的制备及表征。
Eur J Pharm Sci. 2021 Mar 1;158:105619. doi: 10.1016/j.ejps.2020.105619. Epub 2020 Oct 25.
6
Poly(ɛ-caprolactone) and Eudragit E blends modulate the drug release profiles from FDM printlets.聚己内酯和 Eudragit E 共混物调节了 FDM 打印小丸的药物释放曲线。
Int J Pharm. 2023 Nov 25;647:123533. doi: 10.1016/j.ijpharm.2023.123533. Epub 2023 Oct 18.
7
Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary.快速溶解的熔融沉积成型3D打印片剂开发中的挑战、现状及新兴策略:综述与评论
ADMET DMPK. 2023 Jan 1;11(1):33-55. doi: 10.5599/admet.1622. eCollection 2023.
8
Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.熔融沉积成型 3D 打印方法的简化:一步直接粉末打印用于即时释放剂型生产的可行性。
Int J Pharm. 2020 Mar 30;578:119124. doi: 10.1016/j.ijpharm.2020.119124. Epub 2020 Feb 5.
9
An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.一项关于使用聚合物共混物来改善通过熔融沉积建模(FDM)3D打印制备的药物固体分散体的可印刷性并调节其药物释放的研究。
Eur J Pharm Biopharm. 2016 Nov;108:111-125. doi: 10.1016/j.ejpb.2016.08.016. Epub 2016 Sep 2.
10
Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.熔融沉积建模的快速药物释放 3D 打印片剂的配方:用于药物释放、药物-聚合物混溶性和可印刷性筛选的聚合物。
J Pharm Sci. 2018 Jan;107(1):390-401. doi: 10.1016/j.xphs.2017.10.021. Epub 2017 Oct 21.

引用本文的文献

1
The Future of Medicine: How 3D Printing Is Transforming Pharmaceuticals.医学的未来:3D打印如何改变制药行业。
Pharmaceutics. 2025 Mar 19;17(3):390. doi: 10.3390/pharmaceutics17030390.
2
Pharmaceutical 3D Printing Technology Integrating Nanomaterials and Nanodevices for Precision Neurological Therapies.集成纳米材料和纳米器件用于精准神经治疗的药物3D打印技术
Pharmaceutics. 2025 Mar 9;17(3):352. doi: 10.3390/pharmaceutics17030352.
3
Albumin and Polysorbate-80 Coated Sterile Nanosuspensions of Mebendazole for Glioblastoma Therapy.

本文引用的文献

1
Development of a safe pediatric liquisolid self-nanoemulsifying system of triclabendazole for the treatment of fascioliasis.开发一种安全的小儿液体自微乳化给药系统用于治疗片形吸虫病的三氯苯达唑。
Int J Pharm. 2022 Oct 15;626:122163. doi: 10.1016/j.ijpharm.2022.122163. Epub 2022 Sep 5.
2
Aversion liquid-filled drug releasing capsule (3D-RECAL): A novel technology for the development of immediate release abuse deterrent formulations using a fused deposition modelling (FDM) 3D printer.厌恶感填充药物释放胶囊(3D-RECAL):一种使用熔融沉积建模(FDM)3D 打印机开发即时释放的防滥用配方的新技术。
Int J Pharm. 2022 Jun 10;621:121804. doi: 10.1016/j.ijpharm.2022.121804. Epub 2022 May 6.
3
阿霉素白蛋白纳米胶束的处方前研究
AAPS PharmSciTech. 2024 Nov 26;25(8):271. doi: 10.1208/s12249-024-02978-5.
4
propofol permeation across nasal mucosa: A proof-of-concept study for outpatient light sedation via nasal route.丙泊酚经鼻黏膜渗透:一项关于经鼻途径用于门诊浅镇静的概念验证研究。
ADMET DMPK. 2024 Aug 16;12(5):759-768. doi: 10.5599/admet.2403. eCollection 2024.
5
Exploring Environmental Settings to Improve the Printability of Paroxetine-Loaded Filaments by Fused Deposition Modelling.通过熔融沉积建模探索环境设置以提高载有帕罗西汀的长丝的可打印性。
Pharmaceutics. 2023 Nov 16;15(11):2636. doi: 10.3390/pharmaceutics15112636.
6
A Bibliometric Analysis of 3D Printing in Personalized Medicine Research from 2012 to 2022.2012年至2022年个性化医学研究中3D打印的文献计量分析
Pharmaceuticals (Basel). 2023 Oct 26;16(11):1521. doi: 10.3390/ph16111521.
7
Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary.快速溶解的熔融沉积成型3D打印片剂开发中的挑战、现状及新兴策略:综述与评论
ADMET DMPK. 2023 Jan 1;11(1):33-55. doi: 10.5599/admet.1622. eCollection 2023.
Moisture sorption by polymeric excipients commonly used in amorphous solid dispersion and its effect on glass transition temperature: I. Polyvinylpyrrolidone and related copolymers.
聚合物辅料对无定形固体分散体的吸湿性及其对玻璃化转变温度的影响:I. 聚乙烯吡咯烷酮及其相关共聚物。
Int J Pharm. 2022 Mar 25;616:121532. doi: 10.1016/j.ijpharm.2022.121532. Epub 2022 Feb 1.
4
Tailoring amlodipine release from 3D printed tablets: Influence of infill patterns and wall thickness.从 3D 打印片剂中控制氨氯地平释放:填充模式和壁厚的影响。
Int J Pharm. 2021 Dec 15;610:121261. doi: 10.1016/j.ijpharm.2021.121261. Epub 2021 Nov 4.
5
Investigation on hot melt extrusion and prediction on 3D printability of pharmaceutical grade polymers.药用级聚合物的热熔挤出研究及3D打印适性预测
Int J Pharm. 2021 Jul 15;604:120755. doi: 10.1016/j.ijpharm.2021.120755. Epub 2021 May 28.
6
Development and optimization of hot-melt extruded moxifloxacin hydrochloride inserts, for ocular applications, using the design of experiments.利用实验设计开发并优化用于眼部的热熔挤出盐酸莫西沙星插入剂。
Int J Pharm. 2021 Jun 15;603:120676. doi: 10.1016/j.ijpharm.2021.120676. Epub 2021 May 5.
7
Printability, Mechanical and Thermal Properties of Poly(3-Hydroxybutyrate)-Poly(Lactic Acid)-Plasticizer Blends for Three-Dimensional (3D) Printing.用于三维(3D)打印的聚(3-羟基丁酸酯)-聚乳酸-增塑剂共混物的可印刷性、机械性能和热性能
Materials (Basel). 2020 Oct 23;13(21):4736. doi: 10.3390/ma13214736.
8
Exploring tablet design options for tailoring drug release and dose via fused deposition modeling (FDM) 3D printing.探索通过熔融沉积建模(FDM)3D 打印定制药物释放和剂量的片剂设计方案。
Int J Pharm. 2020 Dec 15;591:119987. doi: 10.1016/j.ijpharm.2020.119987. Epub 2020 Oct 16.
9
Abuse deterrent immediate release film technology (ADRIFT): A novel bilayer film technology for limiting intentional drug abuse.滥用防御型速释薄膜技术(ADRIFT):一种限制故意滥用药物的新型双层薄膜技术。
Int J Pharm. 2020 Nov 30;590:119944. doi: 10.1016/j.ijpharm.2020.119944. Epub 2020 Oct 2.
10
Novel On-Demand 3-Dimensional (3-D) Printed Tablets Using Fill Density as an Effective Release-Controlling Tool.使用填充密度作为有效控释工具的新型按需三维(3-D)打印片剂。
Polymers (Basel). 2020 Aug 20;12(9):1872. doi: 10.3390/polym12091872.